127 related articles for article (PubMed ID: 15118590)
1. Regulation of arginase expression by T-helper II cytokines and isoproterenol.
Barksdale AR; Bernard AC; Maley ME; Gellin GL; Kearney PA; Boulanger BR; Tsuei BJ; Ochoa JB
Surgery; 2004 May; 135(5):527-35. PubMed ID: 15118590
[TBL] [Abstract][Full Text] [Related]
2. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.
Munder M; Eichmann K; Modolell M
J Immunol; 1998 Jun; 160(11):5347-54. PubMed ID: 9605134
[TBL] [Abstract][Full Text] [Related]
3. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.
Munder M; Eichmann K; Morán JM; Centeno F; Soler G; Modolell M
J Immunol; 1999 Oct; 163(7):3771-7. PubMed ID: 10490974
[TBL] [Abstract][Full Text] [Related]
4. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages.
Corraliza IM; Soler G; Eichmann K; Modolell M
Biochem Biophys Res Commun; 1995 Jan; 206(2):667-73. PubMed ID: 7530004
[TBL] [Abstract][Full Text] [Related]
5. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.
Holán V; Pindjáková J; Krulová M; Neuwirth A; Fric J; Zajícová A
Transplantation; 2006 Jun; 81(12):1708-15. PubMed ID: 16794538
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity.
Boutard V; Havouis R; Fouqueray B; Philippe C; Moulinoux JP; Baud L
J Immunol; 1995 Aug; 155(4):2077-84. PubMed ID: 7636258
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines.
Modolell M; Corraliza IM; Link F; Soler G; Eichmann K
Eur J Immunol; 1995 Apr; 25(4):1101-4. PubMed ID: 7537672
[TBL] [Abstract][Full Text] [Related]
8. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release.
Salib RJ; Lau LC; Howarth PH
Clin Exp Allergy; 2005 Jun; 35(6):811-9. PubMed ID: 15969674
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of arginase II in patients with different forms of arthritis. Implications of the regulation of nitric oxide.
Corraliza I; Moncada S
J Rheumatol; 2002 Nov; 29(11):2261-5. PubMed ID: 12415579
[TBL] [Abstract][Full Text] [Related]
10. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin.
Munera V; Popovic PJ; Bryk J; Pribis J; Caba D; Matta BM; Zenati M; Ochoa JB
Ann Surg; 2010 Jan; 251(1):120-6. PubMed ID: 20032720
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta differentially regulates TH2 cytokine-induced eotaxin and eotaxin-3 release by human airway smooth muscle cells.
Zuyderduyn S; Hiemstra PS; Rabe KF
J Allergy Clin Immunol; 2004 Oct; 114(4):791-8. PubMed ID: 15480317
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of arginase expression in wound-derived fibroblasts.
Witte MB; Barbul A; Schick MA; Vogt N; Becker HD
J Surg Res; 2002 Jun; 105(1):35-42. PubMed ID: 12069499
[TBL] [Abstract][Full Text] [Related]
13. Role of beta-adrenergic receptors in inflammatory marker expression in Müller cells.
Walker RJ; Steinle JJ
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5276-81. PubMed ID: 17962483
[TBL] [Abstract][Full Text] [Related]
14. Beta adrenoceptor regulation of macrophage arginase activity.
Bernard AC; Fitzpatrick EA; Maley ME; Gellin GL; Tsuei BJ; Arden WA; Boulanger BR; Kearney PA; Ochoa JB
Surgery; 2000 Apr; 127(4):412-8. PubMed ID: 10776432
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor beta.
Zissel G; Schlaak J; Schlaak M; Müller-Quernheim J
Eur Cytokine Netw; 1996; 7(1):59-66. PubMed ID: 8704096
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts.
Asano-Kato N; Fukagawa K; Okada N; Kawakita T; Takano Y; Dogru M; Tsubota K; Fujishima H
Exp Eye Res; 2005 Apr; 80(4):555-60. PubMed ID: 15781283
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-10 production by beta-adrenergic agonists.
Suberville S; Bellocq A; Fouqueray B; Philippe C; Lantz O; Perez J; Baud L
Eur J Immunol; 1996 Nov; 26(11):2601-5. PubMed ID: 8921945
[TBL] [Abstract][Full Text] [Related]
19. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts.
Nonaka M; Pawankar R; Fukumoto A; Ogihara N; Sakanushi A; Yagi T
Clin Exp Allergy; 2004 May; 34(5):804-11. PubMed ID: 15144475
[TBL] [Abstract][Full Text] [Related]
20. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
